Search

A study conducted by researchers at Changchun University of Chinese Medicine explored the use of tenghuang jiangu wan (THJGW) in the treatment of osteoporosis. The study employed network pharmacology and molecular docking techniques, along with experimental validation, to investigate the pharmacodynamic effects of THJGW. The results showed that THJGW effectively increased the number of bone trabeculae and improved structural damage in a rat model of postmenopausal osteoporosis. It was also found to have a protective effect on bone turnover. The study provides valuable insights into the potential therapeutic use of THJGW in osteoporosis treatment. [Extracted from the article]